论文部分内容阅读
采用主要成分抗病毒蛋白仙霉素（ｂｉｏｌｏｇｉｃａｌｓ，ＢＣ３６９），对乙型肝炎病毒（乙肝病毒）转染细胞２２１５株核酸和乙肝病人血清中的核酸多聚酶的体外抑制实验；其抑制率分别为５４．８８％（Ｐ＜０．０１）和４９．０９％（Ｐ＜０．０１）；结果提示ＢＣ３６９直接或间接的抑制乙肝病毒的复制作用
In vitro inhibition experiments were performed on 2215 strains of hepatitis B virus (HBV) -transfected cells and the nucleic acid polymerase of hepatitis B patients using the anti-viral proteins of BC369. The inhibitory rates were 54%. 88% (P <0.01) and 49.09% (P <0.01). The results suggested that BC369 directly or indirectly inhibited the replication of hepatitis B virus